286 related articles for article (PubMed ID: 34029375)
1. Sirtuins as pharmacological targets in neurodegenerative and neuropsychiatric disorders.
Leite JA; Ghirotto B; Targhetta VP; de Lima J; Câmara NOS
Br J Pharmacol; 2022 Apr; 179(8):1496-1511. PubMed ID: 34029375
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide adenine dinucleotide metabolism in the immune response, autoimmunity and inflammageing.
Navarro MN; Gómez de Las Heras MM; Mittelbrunn M
Br J Pharmacol; 2022 May; 179(9):1839-1856. PubMed ID: 33817782
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin deacetylases in neurodegenerative diseases of aging.
Herskovits AZ; Guarente L
Cell Res; 2013 Jun; 23(6):746-58. PubMed ID: 23689277
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of NAD+ dependent histone deacetylases (sirtuins).
Neugebauer RC; Sippl W; Jung M
Curr Pharm Des; 2008; 14(6):562-73. PubMed ID: 18336301
[TBL] [Abstract][Full Text] [Related]
5. Opportunities for histone deacetylase inhibition in amyotrophic lateral sclerosis.
Klingl YE; Pakravan D; Van Den Bosch L
Br J Pharmacol; 2021 Mar; 178(6):1353-1372. PubMed ID: 32726472
[TBL] [Abstract][Full Text] [Related]
6. The role of NAD+ dependent histone deacetylases (sirtuins) in ageing.
Trapp J; Jung M
Curr Drug Targets; 2006 Nov; 7(11):1553-60. PubMed ID: 17100594
[TBL] [Abstract][Full Text] [Related]
7. Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
Aljada A; Dong L; Mousa SA
Curr Opin Investig Drugs; 2010 Oct; 11(10):1158-68. PubMed ID: 20872319
[TBL] [Abstract][Full Text] [Related]
8. Sirtuin Inhibitors: An Overview from Medicinal Chemistry Perspective.
Yoon YK; Oon CE
Anticancer Agents Med Chem; 2016; 16(8):1003-1016. PubMed ID: 26961318
[TBL] [Abstract][Full Text] [Related]
9. Sirtuin Acetylation and Deacetylation: a Complex Paradigm in Neurodegenerative Disease.
Khan H; Tiwari P; Kaur A; Singh TG
Mol Neurobiol; 2021 Aug; 58(8):3903-3917. PubMed ID: 33877561
[TBL] [Abstract][Full Text] [Related]
10. Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy.
Chelladurai P; Boucherat O; Stenmark K; Kracht M; Seeger W; Bauer UM; Bonnet S; Pullamsetti SS
Br J Pharmacol; 2021 Jan; 178(1):54-71. PubMed ID: 31749139
[TBL] [Abstract][Full Text] [Related]
11. Sirtuins: the 'magnificent seven', function, metabolism and longevity.
Dali-Youcef N; Lagouge M; Froelich S; Koehl C; Schoonjans K; Auwerx J
Ann Med; 2007; 39(5):335-45. PubMed ID: 17701476
[TBL] [Abstract][Full Text] [Related]
12. Transcription Regulation by Class III Histone Deacetylases (HDACs)-Sirtuins.
Dai Y; Faller DV
Transl Oncogenomics; 2008 Apr; 3():53-65. PubMed ID: 21566744
[TBL] [Abstract][Full Text] [Related]
13. NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets.
Schemies J; Uciechowska U; Sippl W; Jung M
Med Res Rev; 2010 Nov; 30(6):861-89. PubMed ID: 19824050
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease.
Gan L
Drug News Perspect; 2007 May; 20(4):233-9. PubMed ID: 17637936
[TBL] [Abstract][Full Text] [Related]
15. Sirtuins and Their Roles in Brain Aging and Neurodegenerative Disorders.
Jęśko H; Wencel P; Strosznajder RP; Strosznajder JB
Neurochem Res; 2017 Mar; 42(3):876-890. PubMed ID: 27882448
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins).
Lawson M; Uciechowska U; Schemies J; Rumpf T; Jung M; Sippl W
Biochim Biophys Acta; 2010; 1799(10-12):726-39. PubMed ID: 20601279
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Role of Histone Deacetylase and their Inhibitors in Neurodegenerative Disorders: Current Targets and Future Perspective.
Kumar V; Kundu S; Singh A; Singh S
Curr Neuropharmacol; 2022; 20(1):158-178. PubMed ID: 34151764
[TBL] [Abstract][Full Text] [Related]
18. How environmental enrichment balances out neuroinflammation in chronic pain and comorbid depression and anxiety disorders.
Kimura LF; Novaes LS; Picolo G; Munhoz CD; Cheung CW; Camarini R
Br J Pharmacol; 2022 Apr; 179(8):1640-1660. PubMed ID: 34076891
[TBL] [Abstract][Full Text] [Related]
19. Protective effects and mechanisms of sirtuins in the nervous system.
Zhang F; Wang S; Gan L; Vosler PS; Gao Y; Zigmond MJ; Chen J
Prog Neurobiol; 2011 Nov; 95(3):373-95. PubMed ID: 21930182
[TBL] [Abstract][Full Text] [Related]
20. Sirtuins and Their Implications in Neurodegenerative Diseases from a Drug Discovery Perspective.
Yeong KY; Berdigaliyev N; Chang Y
ACS Chem Neurosci; 2020 Dec; 11(24):4073-4091. PubMed ID: 33280374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
